A first-in-human phase 1 study of IO-202 (anti-LILRB4 mAb) in acute myeloid leukemia (AML) with monocytic differentiation and chronic myelomonocytic leukemia (CMML) patients
DiNardo, C., et al. European Hematology Association 2023. June 8–15, 2023
DiNardo, C., et al. European Hematology Association 2023. June 8–15, 2023